drugset / Trial / NCT02245945
Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this trial is to assess the safety and acceptability of Tenofovir (TFV) 1% gel in adolescent females over 12 weeks of a minimum of twice weekly dosing following the BAT24 regimen.
Timeline
- Start
- —
- Primary completion
- 2015-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenofovir | Small molecule | 4 ml | Other |
Indications
No indication recorded.